Cargando…
Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
Endoglin (CD105), a cell surface co-receptor for transforming growth factor-β, is expressed in proliferating endothelial cells, as well as in cancer cells. We studied endoglin expression and its clinical relevance in effusions, primary tumors, and solid metastatic lesions from women with advanced-st...
Autores principales: | Bock, Annika J., Tuft Stavnes, Helene, Kærn, Janne, Berner, Aasmund, Staff, Anne Cathrine, Davidson, Ben |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093541/ https://www.ncbi.nlm.nih.gov/pubmed/21350924 http://dx.doi.org/10.1007/s13277-011-0157-6 |
Ejemplares similares
-
miRNA profiling along tumour progression in ovarian carcinoma
por: Vaksman, Olga, et al.
Publicado: (2011) -
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
por: Davidson, Ben, et al.
Publicado: (2011) -
Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009) -
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
por: Schaner, Marci E, et al.
Publicado: (2005) -
Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)